Upadacitinib Monotherapy in Vitiligo Associated with Atopic Dermatitis: Killing Two Birds with One Stone
Introduction: An increased risk of developing vitiligo has recently been described in patients with atopic dermatitis (AD). Vitiligo and AD can be associated because of shared pathogenetic pathways, including alterations in the Janus kinases/signal transducer and activator of transcriptio...
Saved in:
| Main Authors: | Lina Maria Magnanimi, Andrea De Berardinis, Maria Esposito, Maria Concetta Fargnoli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2025-02-01
|
| Series: | Case Reports in Dermatology |
| Online Access: | https://karger.com/article/doi/10.1159/000544703 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vitiligo exacerbation during upadacitinib treatment for atopic dermatitis and improvement following a switch to abrocitinib: a case report
by: Zhaoyang Wang, et al.
Published: (2025-12-01) -
Genistein Implications in Radiotherapy: Kill Two Birds with One Stone
by: Xiongxiong Liu, et al.
Published: (2025-01-01) -
Phototherapy in the treatment of atopic dermatitis. Is monotherapy possible?
by: Yu. A. Gallyamova, et al.
Published: (2024-10-01) -
Efficacy of upadacitinib in the management of atopic dermatitis, Crohn’s disease, and hidradenitis suppurativa: one treatment, multiple indications
by: Roberto Bueno-Filho, et al.
Published: (2025-08-01) -
Experience of using the drug upadacitinib in a child with severe atopic dermatitis
by: G. D. Alemanova, et al.
Published: (2025-06-01)